S. Sadeghi and A. Goodarzi, “Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective”, Dermatol Pract Concept, vol. 12, no. 4, p. e2022178, Oct. 2022, doi: 10.5826/dpc.1204a178.